WEDNESDAY, August 6, 2008 9:00 a.m. EDT



    HOPKINTON, Mass., July 23 /EMWNews/ -- Caliper Life

Sciences, Inc. (Nasdaq: CALP) will conduct a conference call discussing the

company's second quarter 2008 financial results at 9:00 a.m. EDT on

Wednesday, August 6. Kevin Hrusovsky, President and Chief Executive Officer

and Peter McAree, Chief Financial Officer, will host the call. Management

will discuss operational and financial results and the company's outlook

for the future.



    A news release discussing Caliper's second quarter 2008 financial

results will be issued Wednesday, August 6 at approximately 7:00 a.m. EDT.



    Participants, please call 888.713.4215 five to ten minutes prior to the

call and use the participant passcode of 30981927. International callers

can access the call by dialing 617.213.4867 and entering the same passcode.

You may also pre-register for the call at

https://www.theconferencingservice.com/prereg/key.process?key=PALUYGE6Q .



    A live webcast of the call can be accessed at http://www.fulldisclosure.com or

on the Caliper website at http://www.caliperLS.com in the Events section of the

Investor Relations page. A webcast replay of the call will remain available

until Caliper's earnings call for the third quarter of 2008.



    Telephone replays of the conference call will be available

approximately two hours after the completion of the call. To access a

telephone playback of the proceedings from August 6 through August 13, dial

888-286-8010 and use the participant passcode of 48521551. International

callers can access the playback by dialing 617-801-6888 and using the same

participant passcode.

    About Caliper Life Sciences



    Caliper Life Sciences is a premier provider of cutting-edge

technologies enabling researchers in the life sciences industry to create

life-saving and enhancing medicines and diagnostic tests more quickly and

efficiently. Caliper is aggressively innovating new technology to bridge

the gap between in vitro assays and in vivo results and then translating

those results into cures for human disease. Caliper's portfolio of

offerings includes state-of-the-art microfluidics, lab automation & liquid

handling, optical imaging technologies, and discovery & development

outsourcing solutions. For more information please visit

http://www.caliperLS.com.